chrisvoncsefalvay/vaers-outcomes huggingface dataset:
TINNITUS It has not stopped I reported it to Dr and she dismissed it and told me we wouldnt know for another 5 years. I fired her. I told another Dr. Dr an infectious disease Dr in another city about it and she told me to ignore it. I went to the emergency room. They did nothing. I finally gave up and found a new PCP but I did not tell him because I thought if I did he wouldnt see me again. I'm also now on high blood pressure meds for the first time in my life. I seriously just want to kill myself it's that bad. Mine is llouder than road noise. It's like a plane taking off in my head and there's massive amounts of pressure. I just want to die. My mother and sister all have it. My life is over.
approx 2wk p/vax pt devel a psoriasis-like rash;the rash has gotten progressively worse, despite various unspecified treatments;
101 fever for three days and counting- I am still experiencing symptoms on Sunday after vaccine on Thursday , aching, chills, body pain, headache, nausea, vomiting, diarrhea, back pain
Pt c/o SOB, nausea, dizziness, chest felt tight and felt like throat was closing.  1st EPI pen given @ 137pm .  Pt took a puff of her personal Albuterol inhaler and EMS called @ 140pm.  APRN'S assessed pt. Symptoms still present 2nd EPI pen given @ 147pm.   Pt symptoms got better when Fire Dept arrived at 155pm.  Ambulance came at 205pm pt taken to ER.
(?) red itchy papules on arms, anterior abdomen and chest and legs less than 24 hours after vaccine.
Fever got as high as 101.1, welt continued to grow, red and warm to touch.
Induration and pain at the site of injection starting the following day of vaccination lasting at least three days.
Narrative: Patient reported nausea and headache following administration of pfizer covid vaccine. Patient required no intervention and was able to depart with no issue.
Child was given 2 Hep B's on same day , one in the combo and then a single dose
2nd Covid vaccine on 9/3/21. Patient had fatigue, Headache + episode of syncope on 9/4/21.
Arm swollen shoulder to elbow w/limited range of motion approx 3 days p/shot;
Admit information:  Delightful 68-year-old white female with past medical history that significant for chronic pain disorder, degenerative disc disease, DJD, history of joint replacement, with history of tobacco use.  Patient was admitted 4/15/2021 due to the fact that she has had ongoing arthralgias and myalgias after undergoing the Moderna vaccination approximately 1 month ago..
p/vax pt c/o lt arm feeling numb from shoulder to elbow;pt went home & gave APAP a/bed;c/o lt arm being numb & cold p/awakened;arm hurt in bicep when mom tries to help raise it;also says coloring/circulation looks less than other arm;6 red
A report was received from a health care professional on 10/23/03 concerning approximately 10 pediatric vaccinees less than 4 years old, of unknown sex, who were inadvertently administered Fluvirin between 10/8/03 and approximately 10/22/03. Between 10/8/03 and approximately 10/22/03, approximately 10 pediatric vaccinees less than 4 years old were inadvertently administered Fluvirin vaccine. No adverse reactions were recorded at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Update 12/9/03: A follow up report was received from a health care professional indicating that a 3 year old female vaccinee inadvertently received Fluvirin on 10/8/03. On 10/8/03, a 3 year old female vaccinee inadvertently received 0.25ml Fluvirin. At the time of reporting the vaccinee did not exhibit any adverse symptoms. No follow up pending. All information received.
L arm:  3.5 cm x 3 cm area of inflamed skin with mild induration to L lower deltoid area; 4.5 cm x 3 cm ovular area of inflamed skin with induration to L SC area, no pustules and no fluctuance. Localized, inflammatory reaction to vaccines.  Low suspicion for cellulitic process at this time. Areas outlined and discussed concerning si/sx with mom. Advised children's Benadryl, cool compress.  Needs f/u in office if sxs worsen.
This patient received last year's (2019-20) influenza Vaccine on 9/26/20 due to oversight in the supply management process. The patient was notified and had not experienced any adverse effects from that vaccine. The patient did return to the office and received the appropriate Fluad Quadrivalent (2020-21) Influenza Vaccine.
TERRIBLE BODY ACHES; HEADACHE; FEVER; This spontaneous report received from a patient via a company representative concerned a 22 year old of unspecified sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced terrible body aches, headache, and fever. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 102 (units unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from terrible body aches, headache, and fever. This report was non-serious. This case, from the same reporter is linked to 20210439367, 20210439312 and 20210440603.
Patient had asked for Pfizer COVID 19 vaccine but was given Moderna COVID 19 vaccine in error
Whole body inflammation water retention adding 1-2 lbs a week. Have gone from 210 lbs. to 222. Muscles aches, fatigue,  Got blood and urine tests on June 7th. Trying to find cause for water retention, fatigue and lightheadedness. Doctor stopped losartan and prescribed a daily  diuretic. The water retention persists and The body still feel stiff and sore. Especially in the morning.
Information had been received on 21-OCT-2016 from a pharmacy technician who reported that on 17-OCT-2016 two unspecified patients (age and gender not reported) were administered PNEUMOVAX 23 pre-filled syringes (lot # M003616, expiration date 06-MAY-2018) (lot # M033086, expiration date 05-MAY-2018) intramuscular. The pharmacy technician stated the two patients called the pharmacy on 19-OCT-2016 experiencing redness and swelling at the injection sites. The patients stated their physician called the redness and swelling a cellulitis and prescribed unspecified antibiotics. Unspecified lab diagnostic studies were performed (results not provided). Present status of the patients was recovering. The pharmacy is requesting a lot check for both lots of PNEUMOVAX 23. No further information is available at this time. Lot # M003616, expiration date 06-MAY-2018 was found not to be valid for PNEUMOVAX 23. Additional information has been requested.
Fever, sore arm (unspecified), body aches (unspecified) Narrative:
Maternal Exposure Before Pregnancy; Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 36-year-old female patient (pregnant) received BNT162b2 (BNT162B2), on 15Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 35 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "obesity" (unspecified if ongoing); "ulcerative colitis" (unspecified if ongoing). Date of last menstrual period: 29Dec2021. The patient was 20 weeks pregnant at the event onset. The patient is expected to deliver a baby(s) on 05Oct2022. Concomitant medication(s) included: BAYER ASPIRIN, start date: 28Jan2022, stop date: 22May2022. Past drug history included: Sulfasalazine, reaction(s): "allergy", notes: known allergies: Sulfasalazine; Amitryptylline, reaction(s): "Allergy", notes: known allergies: Amitryptylline. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset May2022, outcome "unknown" and all described as "Treatment of COVID-19"; MATERNAL EXPOSURE BEFORE PREGNANCY (non-serious), outcome "unknown". Therapeutic measures were taken as a result of covid-19, drug ineffective.  Clinical course information: It was reported that the patient was taking other medications/products within 2 weeks of starting COVID-19 treatment.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the known safety profile and Limited information in the case report a casual association between reported events and the suspect drug BNT162B2 cannot be excluded.
This spontaneous report as received from healthcare student refers to a 17 year old female patient. On 11-NOV-2013, the patient was vaccinated with a first dose of GARDASIL (lot # and expiration date not reported), 0.5 ml, subcutaneous. There was no concomitant medication, pertinent medical history, drug reactions or allergies. On 11-NOV-2013, immediately after administering GARDASIL, the patient began to have ringing in her ears and then experienced tonic clonic jerking and syncope. She was assisted to lie down and her head was lowered. These adverse events were occurred when she was at physician's office. The patient recovered immediately and was able to walk out of the physician's office on her own. No treatment was given for adverse event. None lab diagnostics studies were performed. Upon internal review, tonic clonic jerking was considered as medically significant. Additional information has been requested.
Information has been received from a nurse via a company representative referring to a patient of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided. On an unknown date in 2017, the patient was vaccinated with a dose of GARDASIL 9 (dose, route, lot# and expiration date were not reported) for prophylaxis. After that the patient fainted 15 minutes. The outcome of the event was recovered. The causality was not provided. Upon receipt of follow-up information it was determined that this case is now valid because patient identifiers were received. Follow up information was received on 09-AUG-2018. This spontaneous report concerns a 17 year old male patient. It was reported that the patient did not have any pre-existing physician diagnosed allergies, birth defects and medical conditions. It was also reported that the patient did not have any illness at the time of vaccination. On 08-AUG-2017, the patient was vaccinated with first dose of GARDASIL 9 (lot# N009173 and expiry date 20-NOV-2019) intramuscularly in the right arm and second dose of MENACTRA (lot# U5823AB and expiry date unknown) intramuscularly in the left arm for prophylaxis. It was reported that the patient was vaccinated at a private doctor's office/hospital and the vaccine was purchased with private funds. On approximately 08-AUG-2017 after the vaccines were given the patient was requested to sit in the waiting room for 15 minutes and the patient became pale and fainted while sitting. It was reported that the patient was helped to the exam room and reclined with feet elevated but the patient continued to feel weak and was not well for a period of time. It was reported that prescription drug treatment was not required for the events. It was reported that the patient was discharged without further incident approximately 30 minutes later. It was reported that a temperature excursion did not occur as a result of a reading from a digital data logger. The outcome of the events was reported as recovered. The causality was not provided.
This spontaneous report was received from a registered nurse concerning an approximately 23 year old female patient with no pertinent medical history and no drug reactions or allergies. On 25-SEP-2013, the patient was vaccinated with 0.5 milliliter (ml) of MMR II (lot number and expiry date were reported as J004201 and 12-APR-2015 respectively), subcutaneously. Concomitant therapy included desogestrel, MARVELON. Approximately on an unknown date in September 2013, the patient experienced a 2 inch X 1.5 inch diameter of red area on left dorsal of the arm at the injection site and the area was warm to the touch. The patient sought medical attention. The patient came back 2 days after vaccination to see the nurse. No lab tests were performed. The nurse recommended ibuprofen and icing the area 30 minutes twice a day and if it got worse to seek medical attention especially if there was a fever or rash. The patient came back to see the nurse on 30-SEP-2013 and the area was better and it took 2 weeks after vaccination for the reaction to resolve. Approximately on an unknown date in October 2013, the patient recovered from the events. The relatedness for the events was unknown for MMR II. Additional information has been requested.
Patient stated that her arm has been hurting after receiving vaccination (hurts when the site around the area is touched).
He got a COVID vaccine (location unknown to me) and called a few weeks after vaccine to report symptoms of blood clot was diagnosed this past weekend at emergency room.
My daughter developed a fever of 101.5 rectal on the day after the shots (5/13/04).  She had 1 loose stool this day also and then no abnormal stools thereafter.  On the 2nd day post vaccines she had a fever of 103.5 rectal (5/14/04).  On the 3rd day her temperature was 102 rectal (5/15/04).  The 4th day she was fever free.  She was taken to the doctor on 5/16/04.  A CBC was done and was normal as was she on exam by the doctor (5/15/04).  On 5/17/04 she developed a runny nose.
pt broke out w/3 area, vesicular in appearance x 24hr then crusted over had 1 pock appear few days later then 1 area, 1 wk p/ (both on extremities)
9 hours after vaccination, extreme exhaustion and weakness, as well as pain at injection site. By hour 10, nerve pain throughout spine and peripheral nerves began, increasing to 10/10 pain. Joint inflammation and pain in all joints in body, as well as fever ranging from 100.0-102, lowered to 100 with tylenol.  Unable to get out of bed due to 10/10 pain. Fever lasted for 36 hours.
The patient was vaccinated on Thursday, 11/30/2017. The day following vaccination 12/1, the patient experienced flu like symptoms of chills, feeling feverish, myalgia and lethargy. On 12/2 the patient self treated at home with ALEVE in the evening which palliated her symptoms. 12/3 she had no symptoms. 12/4 she began to notice that the injection site felt swollen. 12/5 the patient came to our office with concerns as the swelling and induration at the site increased. PE findings were R axillary LAD, 7.5 cm long x 7 cm wide circular pattern of induration without erythema surrounding the site of injection and an area of raised erythema approximately 3 cm below injection site measured at 15.5 cm on the diagonal at its longest. 6.5 cm long (lateral aspect) 7.5 cm long (central) to 8 cm long (medial aspect) with a shape similar to a specific county with serpiginous boundary. This area blanched with pressure and the boundary was surrounded by a white border. Two days later on 12/7 patient reports that swelling has resolved and the white border surrounding the area of erythema has disappeared though the area of erythema shifted and began to move distal on her arm.
I had developed runny nose, lung congestion and coughing. I tested positive for COVID-19 on 02/18/2023. I called my provider and the provider prescribed PAXLOVID. I continued with congestion for 3 days. I then returned to normal.
Pt received TD vaccine at a Walk in Adult Clinic on 5/5/06. Stated that in AM of 5/6/06, when awoke, noted left deltoid area tender and slight swelling and redness. On 5/7/06, noticed a swelling and redness had gotten worse and under her left arm swollen as well. C/o pain and difficulty lifting arm due to swelling under the arm. On Monday, 5/8/06, pt went to PCP but was not seen. She call HD and she then came and was seen by NP. She was instructed to apply ice 24 hrs then a warm compress to area. Lt deltoid area was hard, reddened and swollen. Lt lymph node under her arm was swollen as well. Pt c/o pain to touch under her arm and pain when lifting left arm. Instructed to take Advil or Motrin as directed on vial. If pain and swelling got worse 24 hrs was to go to ER or PCP ASAP. She verbalized understanding. She stated that on Friday 5/5/06, she had also started taking Adipex 37.5mg 1/2 tab QD x days. Then she was to take 1 tab QD. She stated that she had applied ice and then warm compress to affected area as instructed. She had taken Advil as well and the swelling and pain had resolved.
Next day minor arm soreness that did not inhibit daily activities which resolved within 36 hours.; No other symptoms experienced beyond standard expected minor injection site soreness.; Approximately 5 minutes post injection, slight tingling in left pinky/ring finger of injected arm.; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 09Apr2021 at 13:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient has not reported any other health issues. The patient did not have any allergies to medications, food, or other products. Concomitant medications included naproxen sodium (ALEVE) since 4 days prior and for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 13:35, approximately 5 minutes post injection, the patient experienced slight tingling in left pinky/ring finger of injected arm. Not very painful but noticeable. Tingling was a bit intermittent and did not interfere with daily activities. It did not spread beyond fingers identified. No other symptoms experienced beyond standard expected minor injection site soreness was reported. After 30 minutes tingling still occurred; but did not worsen beyond initial feeling. The intermittent tingling began to fade during trip home and after approximately 1.5 hours, on 09Apr2021 at 15:05, total tingling resolved. Next day minor arm soreness that did not inhibit daily activities which resolved within 36 hours on an unknown date in Apr2021. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or care. No therapeutic measures were taken for the reported events. The clinical outcome of the events tingling was resolved on 09Apr2021, injection site soreness and minor arm soreness was resolved (after 36 hours) on unknown dates in Apr2021 at the time of this report.  No follow-up attempts are needed. No further information is expected.
Patient donated 880mls of plasma and did not receive the 500mls of saline that would normally be given due to problem with fluid lines. She was given oral fluids for supplementation, patient only consumed 2-3ozs. Patient was given a Tetanus vaccination and was asked to wait in waiting area for 15 minutes for observation. Patient advised staff within 2 minutes that she was light headed and dizzy and was brought back into office. Comfort measures given, patient lost consciousness for 20-30 seconds. EMS called.
This spontaneous report was received from a health care worker. It was reported that on unspecified dates, 10 to 15 patients (unknown gender and age) had received a dose of possibly improperly stored ZOSTAVAX (dose, route and lot # not reported). No adverse event was reported. Additional information has been requested.
Left arm swollen from elbow to shoulder, warm to touch, red, itches. Seen by MD; steroids given and ice applied.
6-10 days after vaccination, large swelling and redness noted to left arm at vaccine site. Site became raised, hard, hot, and red.  Covered large part of arm. Went to physician who was unsure if it was an allergic reaction vs cellulitis, and prescribed antibiotics just in case as the redness was spreading all over arm. This lasted until about 14 days after the vaccine. Did not happen with second dose although at my allergist recommendation I used hydrocortisone cream and took Pepcid for the second dose. During the second dose I just had a 102.5 fever but no arm issues. Just wanted to report because I saw many other people reporting the same issue with moderna.
Patient notices #5 circular, red, itchy, blotches on abdomen and back approximate size of quarter.
I was officially diagnosed with COVID-19 on November 3rd. I had the following symptoms: Fever 101.3 Cough Fatigue Muscle  Headache Loss of taste and smell Congestion Nausea
It sounded like she was dying; This is a spontaneous report. A contactable consumer reported for a female patient (reporter's friend).   A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on Mar2021 (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported.  The consumer reported it sounded like she was dying in 2021, went to 4 or 5 doctors and didn't do anything. The patient was ready to go see a different doctor somewhere there. The event outcome was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
04-23-21 - Woke up super dizzy & was unable to get out of bed for about 30 mins after that I had to VERY carefully move around slowly for weeks after that (until mid June) I also had ringing in my ears for most of that time pretty severe at first & still present but better that when I was dizzy. I had not had this before & it is quite unnerving. I have been doing PT for the dizziness & it has pretty much subsided. I have also had pain (no rash or lymph discomfort or swelling)  just muscular pain in my upper right arm. This started about a month after the vaccination. It is in the arm muscle NOT the bursa. It happens when I have not moved the arm for awhile & I reach for something, etc.. the pain is not severe but obvious  (0 to 10 it is about a 4) & goes down to about a 1 after I move the arm around for 30 seconds or so. I have also had pain & a bit of weakness in my legs & a sharp pain in my left beast (not my chest - the upper left quadrant about 1" below my armpit & 3 inches in the breast tissue. It is a single sharp pain (0 to 10 = 7) and only stays for a few minutes.
Shingles; This case was reported by a consumer via  and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 3 months after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.  It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were reported as follows: This case was reported by the patient for himself or herself. The age at vaccination was not reported. The patient had shingles 3 months after 1st shot. The follow-up would not possible as no contact details were available.
fever, 101.2  began around 1:15 PM Sunday 11/7, the day following administration and resolved after 12 hours
pt recvd vax & exp thrombocytopenia, myalgia, body aches, joint pain, weakness, fatigue, & nausea; The body aches lasted seven days; other sx have not subsided;
Patient experienced low blood glucose of 45 about one hour after vaccination.  She self treated with carbohydrate intake.
3 days after the immunization, patient's arm swelled up from shoulder to wrist, itchy, red rash at injection site. patient had a fever of 102F and rapid heart rate.